Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Net Income (2021 - 2025)

Historic Net Income for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$14403.4.

  • Molecular Partners Ag's Net Income fell 1006.35% to -$14403.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 10007.12%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Net Income of -$14403.4 as of Q3 2025, which was down 1006.35% from $4.7 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Net Income peaked at $165.2 billion during Q1 2022, and registered a low of -$18.2 billion during Q1 2024.
  • For the 5-year period, Molecular Partners Ag's Net Income averaged around $8.9 billion, with its median value being -$16136.5 (2025).
  • As far as peak fluctuations go, Molecular Partners Ag's Net Income skyrocketed by 90218183697.23% in 2022, and later crashed by 26066.73% in 2023.
  • Molecular Partners Ag's Net Income (Quarter) stood at $51.7 billion in 2021, then tumbled by 99.76% to $122.2 million in 2022, then tumbled by 100.77% to -$934828.2 in 2023, then soared by 981.48% to $8.2 million in 2024, then crashed by 100.17% to -$14403.4 in 2025.
  • Its Net Income was -$14403.4 in Q3 2025, compared to $4.7 million in Q2 2025 and -$16136.5 in Q1 2025.